Hiperhomocysteinemia (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hiperhomocysteinemia" in Polish language version.

refsWebsite

Global rank Polish rank

10nih.gov

4^th place

7^th place

8doi.org

2^nd place

6^th place

7worldcat.org

5^th place

2^nd place

doi.org

dx.doi.org

AleksandraA. Baszczuk AleksandraA., ZygmuntZ. Kopczyński ZygmuntZ., Hiperhomocysteinemia u chorych na schorzenia układu krążenia, „Postepy Higieny i Medycyny Doswiadczalnej”, 68, 2014, s. 579–589, DOI: 10.5604/17322693.1102340, ISSN 1732-2693, PMID: 24864108 [dostęp 2018-07-20] .
ShuyuS. Zhou ShuyuS., ZhizhongZ. Zhang ZhizhongZ., GelinG. Xu GelinG., Notable epigenetic role of hyperhomocysteinemia in atherogenesis, „Lipids in Health and Disease”, 13, 2014, DOI: 10.1186/1476-511X-13-134, ISSN 1476-511X, PMID: 25142226, PMCID: PMC4156629 [dostęp 2018-07-20] .
G.G. Casella G.G. i inni, Hyperhomocysteinemia in patients with Crohn's disease, „Techniques in Coloproctology”, 17 (5), 2013, s. 497–500, DOI: 10.1007/s10151-013-0992-0, ISSN 1128-045X, PMID: 23471541 [dostęp 2018-07-20] .
MelindaM. Farkas MelindaM. i inni, Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?, „Journal of Alzheimer's disease: JAD”, 33 (4), 2013, s. 1097–1104, DOI: 10.3233/JAD-2012-121378, ISSN 1875-8908, PMID: 23099812 [dostęp 2018-07-20] .
MeenakshiM. Sharma MeenakshiM., ManishaM. Tiwari ManishaM., Rakesh KumarR.K. Tiwari Rakesh KumarR.K., Hyperhomocysteinemia: Impact on Neurodegenerative Diseases, „Basic & Clinical Pharmacology & Toxicology”, 117 (5), 2015, s. 287–296, DOI: 10.1111/bcpt.12424, ISSN 1742-7843, PMID: 26036286 [dostęp 2018-07-20] .

doi.org

S. Zoungas, BP. McGrath, P. Branley, PG. Kerr i inni. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.. „J Am Coll Cardiol”. 47 (6), s. 1108-16, 2006. DOI: 10.1016/j.jacc.2005.10.064. PMID: 16545638.
Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. „N Engl J Med”. 354. 15, s. 1629-32, 2006. DOI: 10.1056/NEJMoa060900. PMID: 16531613.
Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. „N Engl J Med”. 354. 15, s. 1629-32, 2006. DOI: 10.1056/NEJMoa055227. PMID: 16531614.

nih.gov

ncbi.nlm.nih.gov

AleksandraA. Baszczuk AleksandraA., ZygmuntZ. Kopczyński ZygmuntZ., Hiperhomocysteinemia u chorych na schorzenia układu krążenia, „Postepy Higieny i Medycyny Doswiadczalnej”, 68, 2014, s. 579–589, DOI: 10.5604/17322693.1102340, ISSN 1732-2693, PMID: 24864108 [dostęp 2018-07-20] .
ShuyuS. Zhou ShuyuS., ZhizhongZ. Zhang ZhizhongZ., GelinG. Xu GelinG., Notable epigenetic role of hyperhomocysteinemia in atherogenesis, „Lipids in Health and Disease”, 13, 2014, DOI: 10.1186/1476-511X-13-134, ISSN 1476-511X, PMID: 25142226, PMCID: PMC4156629 [dostęp 2018-07-20] .
Bradley A.B.A. Maron Bradley A.B.A., JosephJ. Loscalzo JosephJ., Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?, „Current Atherosclerosis Reports”, 9 (5), 2007, s. 375–383, ISSN 1523-3804, PMID: 18001620 [dostęp 2018-07-20] .
G.G. Casella G.G. i inni, Hyperhomocysteinemia in patients with Crohn's disease, „Techniques in Coloproctology”, 17 (5), 2013, s. 497–500, DOI: 10.1007/s10151-013-0992-0, ISSN 1128-045X, PMID: 23471541 [dostęp 2018-07-20] .
MelindaM. Farkas MelindaM. i inni, Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?, „Journal of Alzheimer's disease: JAD”, 33 (4), 2013, s. 1097–1104, DOI: 10.3233/JAD-2012-121378, ISSN 1875-8908, PMID: 23099812 [dostęp 2018-07-20] .
MeenakshiM. Sharma MeenakshiM., ManishaM. Tiwari ManishaM., Rakesh KumarR.K. Tiwari Rakesh KumarR.K., Hyperhomocysteinemia: Impact on Neurodegenerative Diseases, „Basic & Clinical Pharmacology & Toxicology”, 117 (5), 2015, s. 287–296, DOI: 10.1111/bcpt.12424, ISSN 1742-7843, PMID: 26036286 [dostęp 2018-07-20] .
SiS. Cheng SiS., JuanJ. Feng JuanJ., XianX. Wang XianX., [Research advances in the treatment of hyperhomocysteinemia], „Sheng Li Ke Xue Jin Zhan [Progress in Physiology]”, 42 (5), 2011, s. 329–334, ISSN 0559-7765, PMID: 22242398 [dostęp 2018-07-20] .
S. Zoungas, BP. McGrath, P. Branley, PG. Kerr i inni. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.. „J Am Coll Cardiol”. 47 (6), s. 1108-16, 2006. DOI: 10.1016/j.jacc.2005.10.064. PMID: 16545638.
Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. „N Engl J Med”. 354. 15, s. 1629-32, 2006. DOI: 10.1056/NEJMoa060900. PMID: 16531613.
Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. „N Engl J Med”. 354. 15, s. 1629-32, 2006. DOI: 10.1056/NEJMoa055227. PMID: 16531614.

worldcat.org

AleksandraA. Baszczuk AleksandraA., ZygmuntZ. Kopczyński ZygmuntZ., Hiperhomocysteinemia u chorych na schorzenia układu krążenia, „Postepy Higieny i Medycyny Doswiadczalnej”, 68, 2014, s. 579–589, DOI: 10.5604/17322693.1102340, ISSN 1732-2693, PMID: 24864108 [dostęp 2018-07-20] .
ShuyuS. Zhou ShuyuS., ZhizhongZ. Zhang ZhizhongZ., GelinG. Xu GelinG., Notable epigenetic role of hyperhomocysteinemia in atherogenesis, „Lipids in Health and Disease”, 13, 2014, DOI: 10.1186/1476-511X-13-134, ISSN 1476-511X, PMID: 25142226, PMCID: PMC4156629 [dostęp 2018-07-20] .
Bradley A.B.A. Maron Bradley A.B.A., JosephJ. Loscalzo JosephJ., Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?, „Current Atherosclerosis Reports”, 9 (5), 2007, s. 375–383, ISSN 1523-3804, PMID: 18001620 [dostęp 2018-07-20] .
G.G. Casella G.G. i inni, Hyperhomocysteinemia in patients with Crohn's disease, „Techniques in Coloproctology”, 17 (5), 2013, s. 497–500, DOI: 10.1007/s10151-013-0992-0, ISSN 1128-045X, PMID: 23471541 [dostęp 2018-07-20] .
MelindaM. Farkas MelindaM. i inni, Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?, „Journal of Alzheimer's disease: JAD”, 33 (4), 2013, s. 1097–1104, DOI: 10.3233/JAD-2012-121378, ISSN 1875-8908, PMID: 23099812 [dostęp 2018-07-20] .
MeenakshiM. Sharma MeenakshiM., ManishaM. Tiwari ManishaM., Rakesh KumarR.K. Tiwari Rakesh KumarR.K., Hyperhomocysteinemia: Impact on Neurodegenerative Diseases, „Basic & Clinical Pharmacology & Toxicology”, 117 (5), 2015, s. 287–296, DOI: 10.1111/bcpt.12424, ISSN 1742-7843, PMID: 26036286 [dostęp 2018-07-20] .
SiS. Cheng SiS., JuanJ. Feng JuanJ., XianX. Wang XianX., [Research advances in the treatment of hyperhomocysteinemia], „Sheng Li Ke Xue Jin Zhan [Progress in Physiology]”, 42 (5), 2011, s. 329–334, ISSN 0559-7765, PMID: 22242398 [dostęp 2018-07-20] .